Terrebonne General Expands Cardiology Services
- Category: News
- Posted On:
- Written By: Rhonda Alfred
Terrebonne General Medical Center (TGMC) is proud to announce the completion of expanded cardiology services that includes a state of the art Electrophysiology (EP) surgical suite and four Cardiac Catheterization Labs (Cath Lab). With this expansion, TGMC is the only facility in the region to offer this level of advanced and expanded cardiology services to treat complex and highly specialized cardiology procedures.
The leading edge EP Surgical Suite was built to accommodate the growing patient volume and is equipped with the world’s first high definition detector, the Alphenix Core + and Alphenix Hi-Def Detector from Canon Medical Systems USA. Electrophysiology is the study of the heart’s electrical system which is used to diagnose irregular heartbeats or arrhythmia. These procedures, done in partnership with Cardiovascular Institute of the South (CIS), such as cardiac ablations, treat heart rhythm disorders often reducing the need for medications. These procedures are less invasive and performed in an outpatient setting, leading to quicker recoveries and better outcomes for patients. With this addition, TGMC is now the only facility in the region offering a dedicated EP Lab with advanced cardiac electrophysiology to treat patients with an irregular heartbeat.
The EP expansion allows for TGMC and CIS’ Structural Heart Program to continue to expand to meet the growing needs of the community. The Structural Heart Program provides minimally invasive procedures to treat life-threatening valve disorders and structural heart defects. Through collaboration between CIS’ interventional cardiologists and TGMC’s cardiovascular surgeons, the team provides leading edge cardiology solutions to ensure patients have the best possible outcomes. Conditions treated include Mitral and Aortic Valve Stenosis, Mitral Valve Regurgitations, and Congenital Heart Defects. Treatment options include Transcatheter Aortic Valve Replacement (TAVR), Balloon Valvuloplasty, Percutaneous Mitral Valve Clip Placement, and closure of Atrial Septal Defects and Patent Foramen Ovale.
In addition, TGMC has expanded its number of Interventional cardiac Cath Labs. TGMC now offers four state-of-the-art Alphenix Dual Plane rooms by Cannon Medical Systems USA, Inc. Each Cath Lab equipped with the latest technology to perform coronary and peripheral procedures, with unmatched flexibility and patient safety.
This innovative technology provides physicians and medical personnel with superior imaging allowing clinicians to see fine details during complex interventional procedures such as stent positioning, wire and catheter navigation through the stent, and observation of stent deployment. As patient safety is always a top priority, the new technology offers low dose optimizing software tools to help minimize radiation exposure to patients, physicians, nurses and technologists.
“TGMC is committed to providing exclusive cardiac care to our community,” said Phyllis Peoples, TGMC President and CEO. “With the additional space and innovative technology, our patients can be assured that they do not need to travel far for exceptional cardiac care.”
On average, TGMC provides over 3,250 cardiac procedures annually. TGMC received the CareChex award by Quantros for being ranked #1 in the market and top 10% in the nation, region and state for cardiac care. The CareChex award is an honor achieved through the efforts of both TGMC and CIS.
To learn more about cardiology services, visit tghealthsystem.com.